A 12-week Randomized Study to Evaluate Oral Istradefylline in Subjects With Moderate to Severe Parkinson's Disease
about
A 12-week Randomized Study to Evaluate Oral Istradefylline in Subjects With Moderate to Severe Parkinson's Disease
description
clinical trial
@en
klinisch onderzoek
@nl
name
A 12-week Randomized Study to ...... to Severe Parkinson's Disease
@en
type
label
A 12-week Randomized Study to ...... to Severe Parkinson's Disease
@en
prefLabel
A 12-week Randomized Study to ...... to Severe Parkinson's Disease
@en
P17
P1050
P1476
A Phase 3, 12-week, Double-Bli ...... to Severe Parkinson's Disease
@en
P1813
KW-6002
@en
P3098
NCT01968031
P4844
P580
2013-10-01T00:00:00Z
P582
2016-10-01T00:00:00Z